Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Alandaleeb, Ali
PIOQ8, NCT04604223: Effect of Pioglitazone on T2DM Patients With COVID-19	Recruiting	4	1506	RoW	Pioglitazone 45 mg	Dasman Diabetes Institute, Ministry of Health, Kuwait, Texas Diabetes Institute, Kuwait University	Covid19, Type 2 Diabetes	06/21	06/21